By Professor David Goldstein

Journal articles

Yip D; Karapetis C; Strickland C; Steer C; Goldstein D, 2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, 4

Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240

Mok KW; Goldstein D, 2006, 'Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?', Asia-Pacific Journal of Clinical Oncology, 2, pp. 175 - 179

Underhill CR; Goldstein D; Grogan PB, 2006, 'Inequity in rural cancer survival in Australia is not an insurmountable problem', Medical Journal of Australia, 6, pp. 479 - 480

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, 12, pp. 4481 - 4484

Goldstein D; Ackland S; Bell DR; Olver IN; Davis ID; Rosenthal M; Toner GC; Pinel MC; Byrne M, 2006, 'Phase II study of vinflunine in patients with metastatic renal cell carcinoma', Investigational New Drugs, 24, pp. 429 - 434

Grimison PS; T Chin M; Harrison ML; Goldstein D; Chin M, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, 6, pp. 117, http://dx.doi.org/10.1186/1471-2407-6-117

Shepherd LM; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, 32, pp. 453 - 461

Barlow-Stewart K; Yeo SS; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Towards cultural competence in cancer genetic counselling and genetics education: lessons learned from Chinese-Australians', Genetics in Medicine, 8, pp. 24 - 32

Van Glabbeke M; Verweij J; Casali PG; Le Cesne A; Hohenberger P; Ray-Coquard I; Schlemmer M; Van Oosterom AT; Goldstein D; Sciot R; Hogendoorn PCW; Brown M; Bertulli R; Judson IR, 2005, 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study', Journal of Clinical Oncology, 23, pp. 5795 - 5804, http://dx.doi.org/10.1200/JCO.2005.11.601

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines', Oncology, 69, pp. 224 - 238, http://dx.doi.org/10.1159/000088070

Grimison P; Goldstein D; Yeo B, 2005, 'Editor's quiz: GI snapshot. An unusual abdominal mass', Gut, 54, http://dx.doi.org/10.1136/gut.2004.051342

Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A; Matthews J; Simes J; Beller E; Fitzgerald L; Gray E; Dodds H; Marks P; Hayden P; Erratt A; Monro C; Pike R; Walpole E; Gotley D; Thomson D; Harvey J; Martin I; Burmeister E; Jamieson G; Borg M; Yeoh E; Olver I; Caruso D; Game P; Joseph D; Spry N; Minchin D; Cameron F; Faulkner K; Einhorn S; Dewar J; Gillies J; Johnson C; Kilmurray J; Neely M; Carmody M; Mackintosh J; Millar J; O'Brien P; Schwartz M; Smith R; Woods S; Nathanson L; O'Loughlin B; Grimes D; Cheuk R; Dickie G; Keller J; Archer S; Bayliss E; Gray B; Trotter J; Ransom D; Shepherd J; Stone C; Thompson I; Guiney M; Henderson M; Thomas R; Kian M; Ngan S; Rischin D; Walcher V; Zalcberg J; North J; Costello S; Perez D; Whitely D; Wyllie A; Avramovic J; Donnolly P; Fon P; Collins M; McIntosh R; Melville P; Bell R; Kirrof G; Harris I; McLennan R; Monro W; Aroney R; Falconer K; Cullingford G; Davidson A; Randell C; Berry M; Delaney G; Moylan E; Burns D; Goldstein D; Zissiadis M, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6

Grimison P; Goldstein D; Schneeweiss J; Murray N, 2005, 'Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms', Internal Medicine Journal, 35, pp. 136 - 137, http://dx.doi.org/10.1111/j.1445-5994.2004.00757.x

Yip D; Goldstein D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, 31, pp. 236 - 241

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)', Journal of Clinical Oncology, 23, pp. 3581 - 3581, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3581

Goldstein D; Mitchell P; Friedlander ML; Michael M; Beale P; Zalcberg JR; White S; Clarke SJ, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426

Thewes B; Meiser B; Taylor AJ; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, 23, pp. 5155 - 5165

Goldstein D; Tan BS; Rossleigh MA; Haindl W; Walker BM; Dixon J, 2005, 'Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission tomography with CT for the Assessment of Treatment Response - An AGITG Study', Oncology, 69, pp. 326 - 332

Glabbeke M; Verweij J; Casali P; Le Cesne A; Hohenberger P; Ray-Coquard I; Goldstein D; Schlemmer M; Van Oosterom AT; Sciot R; Hogendoorn P; Brown M; Bertulli R; Judson I, 2005, 'Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A Eurpoean Organisation for Research and Treatment of Cancer etc.', Journal of Clinical Oncology, 23, pp. 5795 - 5804

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines', Cancer Letters, 225, pp. 61 - 74

Goldstein D; Taylor JL; Marx G, 2005, 'Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience', Internal Medicine Journal, 35, pp. 34 - 38

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, 32, pp. 51 - 60

Ngan SY; Fisher R; Burmeister B; Mackay J; Goldstein D; Kneebone AB; Schache D; Joseph D; McKendrick J; Long T; McClure B; Rischin D, 2005, 'Promising results of a cooperative group phase II trial of preoperative chemoradiation For locally advanced rectal cancer (TROG 9801)', Diseases of the Colon and Rectum, 48, pp. 1389 - 1396

Goldstein D; Grimpen F; Yip D; McArthur G; Waring P; Loughrey M; Beshay V; Chong G, 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, 6, pp. 724 - 727

Goldstein D; van Hazel G; Pavlakis N; Olver I, 2005, 'Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with Irinotecan. A phase I dose escalation study', Journal of Clinical Oncology, 23, pp. 3701 - 3701, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3701

Goldstein D, 2005, 'The role of chemotherapy in the treatment of pancreatic carcinoma', Australian Prescriber, 28, pp. 42 - 44

Meiser B; Yeo SS; Barlow-Stewart K; Goldstein D; Tucker K; Eisenbruch M, 2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho - Oncology, 14, pp. 174 - 186

Brown RF; Butow PN; Sharrock MA; Henman M; Boyle F; Goldstein D; Tattersall MHN, 2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x

Hughes BGM; Yip D; Chao M; Gibbs P; Carroll S; Goldstein D; Burmeister B; Karapetis C, 2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x

Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G, 2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, 4, pp. 74, http://dx.doi.org/10.1186/1471-2407-4-74

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia , 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508

Daly EB; Chen GW; Sun L; Friedlander ML; Goldstein D; Beer D; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, 19, pp. 170 - 172

Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MH, 2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, 22, pp. 1721 - 1730

Loi S; Goldstein D; Clezy KR; Milliken ST; Hoy JF; Chipman M, 2004, 'Castleman`s disease and HIV infection in Australia', HIV Medicine, 5, pp. 157 - 162

Qu XJ; Yang JL; Russell PJ; Goldstein D, 2004, 'Change in epidermal growth factor receptor expression in human bladdercancer cell lines following interferon-alpha treatment', Journal of Urology, 172, pp. 733 - 738

Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384

Apte MV; Wilson JS; Park S; Phillips PA; Santucci N; Goldstein D; Ramm GA; Buchler M; Friess H; Mccarroll JA; Merrett ND; Pirola RC, 2004, 'Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells', Pancreas, 29, pp. 179 - 187

Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695

Goldstein D; Apte MV; Carroll SL; Keogh G, 2004, 'Modern management of pancreatic cancer', Internal Medicine Journal, 34, pp. 475 - 481

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, 53, pp. 123 - 129

Jong KE; Smith DP; Yu XQ; O Connell DL; Goldstein D; Armstrong BK, 2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, 180, pp. 618 - 622

Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x

Shannon JF; Mackenzie-Wood AR; Wood G; Goldstein D, 2003, 'Cicatricial pemphigoid in non-Hodgkin`s lymphoma', Internal Medicine Journal, 33, pp. 396 - 397

Ngan SY; Fisher R; Burmeister B; Rischin D; Mackay J; Kneebone A; Joseph D; McKendrick J; Goldstein D; McClure B; Lim Joon D, 2003, 'Delayed relapse following preoperative chemoradiation and surgery for rectal cancer', International Journal of Radiation Oncology*Biology*Physics, 57, pp. S220 - S220, http://dx.doi.org/10.1016/s0360-3016(03)01035-6

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403

Eisenbruch IM; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, 59, pp. 235 - 248

Back to profile page